newsfilter
← Latest News
GlobeNewswire·

Sagimet Biosciences Announces Upcoming Presentation at AASLD—The Liver Meeting® 2025

SAN MATEO, Calif., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (NASDAQ:SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic